ARS Pharmaceuticals, Inc. Insider Transactions
ARS Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Chakma Justin
CBO |
Sell | 27,272 @ $12.06 | $328,969 | 136,380 | 12/13/2024 | 12/13/2024 | |
|
Chakma Justin
CBO |
Sell | 117,333 @ $12.27 | $1.44 M | 136,380 | 12/12/2024 | 12/13/2024 | |
|
Dorsey Brian
COO |
Sell | 25,000 @ $12.30 | $307,433 | 6,024 | 12/12/2024 | 12/13/2024 | |
|
Dorsey Brian
COO |
Sell | 15,000 @ $12.43 | $186,426 | 6,024 | 12/11/2024 | 12/13/2024 | |
|
Tanimoto Sarina
10 percent owner, CHIEF MEDICAL OFFICER |
Sell | 50,000 @ $13.16 | $658,155 | 1,148,499 | 12/10/2024 | 12/11/2024 | |
| Sell | 50,000 @ $13.16 | $658,155 | 1,148,499 | 12/10/2024 | 12/11/2024 | ||
|
Chakma Justin
CBO |
Sell | 50,000 @ $13.15 | $657,625 | 136,380 | 12/10/2024 | 12/12/2024 | |
|
Chakma Justin
CBO |
Sell | 50,000 @ $14.23 | $711,615 | 136,380 | 12/06/2024 | 12/06/2024 | |
|
Chakma Justin
CBO |
Sell | 49,640 @ $14.13 | $701,642 | 136,380 | 12/05/2024 | 12/06/2024 | |
|
Chakma Justin
CBO |
Sell | 45,000 @ $13.95 | $627,944 | 136,380 | 12/04/2024 | 12/06/2024 | |
|
Shawver Laura
Director |
Sell | 14,772 @ $13.75 | $203,109 | 210,346 | 12/04/2024 | 12/04/2024 | |
|
Karas Eric
Chief Commercial Officer |
Sell | 6,283 @ $14.00 | $87,962 | 5,693 | 12/04/2024 | 12/04/2024 | |
|
Chakma Justin
CBO |
Sell | 45,000 @ $13.19 | $593,402 | 136,380 | 12/03/2024 | 12/04/2024 | |
|
Shawver Laura
Director |
Sell | 87,984 @ $13.26 | $1.17 M | 210,346 | 12/03/2024 | 12/04/2024 | |
|
Chakma Justin
CBO |
Sell | 45,000 @ $13.67 | $615,218 | 136,380 | 12/02/2024 | 12/04/2024 | |
|
Shawver Laura
Director |
Sell | 96,343 @ $13.55 | $1.31 M | 211,247 | 12/02/2024 | 12/04/2024 | |
|
Shawver Laura
Director |
Sell | 901 @ $14.34 | $12,922 | 210,346 | 12/02/2024 | 12/04/2024 | |
|
Karas Eric
Chief Commercial Officer |
Sell | 3,717 @ $14.11 | $52,461 | 5,693 | 12/02/2024 | 12/04/2024 | |
|
Chakma Justin
CBO |
Sell | 25,000 @ $14.39 | $359,750 | 136,380 | 11/27/2024 | 11/27/2024 | |
|
Chakma Justin
CBO |
Sell | 42,186 @ $14.05 | $592,570 | 161,380 | 11/26/2024 | 11/27/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ARS Pharmaceuticals, Inc. FAQ's
The list of insiders at ARS Pharmaceuticals, Inc. includes Tanimoto Sarina, Lowenthal Richard E, RA CAPITAL MANAGEMENT, L.P., Karas Eric, Dorsey Brian, ORBIMED ADVISORS LLC, Thompson Peter A., Scott Kathleen D., Flynn James E, Chakma Justin, Shawver Laura.
Insiders have sold a total of 5.06 M ARS Pharmaceuticals, Inc. shares in the last 12 months for a total of 65.09 M sold.
The following insiders have sold ARS Pharmaceuticals, Inc. shares in the last 12 months: Tanimoto Sarina ($11.45 M), Lowenthal Richard E ($11.45 M), Karas Eric ($420,423), Dorsey Brian ($1.24 M), ORBIMED ADVISORS LLC ($12.59 M), Thompson Peter A. ($12.59 M), Scott Kathleen D. ($200,000), Flynn James E ($5.38 M), Chakma Justin ($7.09 M), Shawver Laura ($2.69 M),
Insiders have purchased a total of 1.40 M ARS Pharmaceuticals, Inc. shares in the last 12 months for a total of 13.29 M.
The following insiders have purchased ARS Pharmaceuticals, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($13.29 M),